Silence Therapeutics Plc (SLNCF)
Silence Therapeutics Market Cap : 150.21M for May 29, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Biodexa Pharmaceuticals Plc | 2.589M |
| NuCana Plc | 9.698M |
| Mereo BioPharma Group Plc | 54.70M |
| Compass Pathways Plc | 1.762B |
| HemoGenyx Pharmaceuticals Plc | 15.84M |
Market Cap Related Metrics
| PS Ratio | 179.03 |
| Price to Book Value | 3.040 |
| Price | 1.06 |
| Earnings Yield | -49.95% |